↓ Skip to main content

Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2018
Altmetric Badge

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
38 Mendeley